Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.

Bibliographic Details
Main Authors:	Ulrika Marking, Margriet den Boer, Asish Kumar Das, Elshafie Mohamed Ahmed, Victoria Rollason, Be-Nazir Ahmed, Robert N Davidson, Koert Ritmeijer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-06-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4055542?pdf=render

Similar Items

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
by: Anand Ballabh Joshi, et al.
Published: (2023-02-01)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
by: Greta Volpedo, et al.
Published: (2021-06-01)

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
by: Ermias Diro, et al.
Published: (2019-01-01)

Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
by: Gajendra Kumar Katara, et al.
Published: (2012-01-01)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015-04-01)

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015-01-01)

Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015-12-01)

Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
by: Charles Abongomera, et al.
Published: (2019-04-01)

Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
by: Abdul Mabood Khan, et al.
Published: (2014-03-01)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.
by: Joyce Pijpers, et al.
Published: (2019-02-01)

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
by: Vidya Nand Rabi Das, et al.
Published: (2017-01-01)

Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states
by: Suman Saurabh, et al.
Published: (2020-01-01)

Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients.
by: Gajendra Kumar Katara, et al.
Published: (2011-01-01)

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
by: Dinesh Mondal, et al.
Published: (2010-10-01)

Post kala-azar dermal leishmaniasis
by: Nilay Kanti Das
Published: (2020-01-01)

Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post–kala-azar dermal leishmaniasis (PKDL) patients
by: Sophie I. Owen, et al.
Published: (2021-02-01)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
by: Charles Abongomera, et al.
Published: (2018-05-01)

Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion.
by: Nath, P, et al.
Published: (2014)

Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
by: Sabrina Cencig, et al.
Published: (2011-06-01)

Extensive post-kala-azar dermal leishmaniasis
by: Tanvi Dev, et al.
Published: (2018-01-01)

Epidemiology of post-kala-azar dermal leishmaniasis
by: Pramit Ghosh, et al.
Published: (2021-01-01)

Dermoscopy of post kala-azar dermal leishmaniasis
by: Abhijeet K Jha, et al.
Published: (2018-01-01)

Histopathology of post kala-azar dermal leishmaniasis
by: V Ramesh, et al.
Published: (2020-01-01)

Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
by: Sakib Burza, et al.
Published: (2014-01-01)

Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis
by: Madhurima Roy, et al.
Published: (2023-04-01)

Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
by: Madhurima Roy, et al.
Published: (2023-04-01)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
by: Charles Abongomera, et al.
Published: (2016-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2003-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2002-01-01)

Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Cytotoxicity of Amphotericin B and AmBisome: In Silico and In Vivo Evaluation Employing the Chick Embryo Model
by: Ahmad Khosravi, et al.
Published: (2022-06-01)

The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles
by: Louise Walker, et al.
Published: (2018-03-01)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
by: Ridwanur Rahman, et al.
Published: (2017-05-01)

PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
by: Swagata Ganguly, et al.
Published: (2015-01-01)

Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
by: Keerti Kaumudee Dixit, et al.
Published: (2020-01-01)

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
by: Eduard E Zijlstra, et al.
Published: (2017-11-01)

Challenges for management of post kala-azar dermal leishmaniasis and future directions
by: Mondal D, et al.
Published: (2014-11-01)

Atypical post kala azar dermal leishmaniasis with ′′Muzzle area′′ swelling
by: Sandeep Arora, et al.
Published: (2015-01-01)

Post-kala-azar dermal Leishmaniasis in two different clinical contexts
by: Daniel Holanda Barroso, et al.
Published: (2015-06-01)